导读:本文包含了平坦部玻璃体切割术论文开题报告文献综述及选题提纲参考文献，主要关键词:晶状体后囊膜,睫状体平坦部,后发性白内障
平坦部玻璃体切割术论文文献综述
刘志强,孙元英[1]（2015）在《经睫状体平坦部行晶状体后囊膜切开联合前段玻璃体切割治疗后发性白内障的疗效观察》一文中研究指出目的探讨经睫状体平坦部行晶状体后囊膜切开联合前段玻璃体切割术治疗后发性白内障的临床疗效。方法于局麻下对人工晶体眼的后发性白内障患者73例(80眼)作为治疗组,经睫状体平坦部行晶状体后囊膜切开术联合前段玻璃体切割治疗。同时选取行Nd∶YAG激光后囊膜切开术60例(60眼)作为对照组。术后应用抗生素、激素眼药水治疗。观察术中的并发症,手术前后的视力变化情况。同时行OCT检查患眼手术前后黄斑区的厚度变化。随诊半年。结果两组术后视力均好于术前视力(P<0.05)。对照组术后黄斑区厚度改变与治疗组比较有差异。结论经睫状体平坦部切口行晶状体后囊膜切开联合前段玻璃体切割术是治疗后发性白内障的一种安全、有效的方法,是对Nd∶YAG激光后囊膜切开术的有利补充。(本文来源于《中华临床医师杂志(电子版)》期刊2015年19期）
何异,唐晓昭[2]（2009）在《经睫状体平坦部玻璃体切割术并腔内激光治疗Eales病》一文中研究指出目的观察经睫状体平坦部玻璃体切割术联合激光光凝治疗Eales病的临床疗效。方法回顾性分析36例42眼经睫状体平坦部玻璃体切割术联合眼内激光治疗Eales病患者的临床资料。结果术后视力明显提高28眼(67%),术后视力提高37眼(88%),无提高5眼(12%)。结论经睫状体平坦部玻璃体切割联合激光光凝是治疗Eales病的有效方法。(本文来源于《四川医学》期刊2009年07期）
付中静[3]（2008）在《睫状体平坦部玻璃体切割术联合或不联合内界膜剥离术治疗纤维组织增生性糖尿病》一文中研究指出目的评价睫状体平坦部玻璃体切割术治疗增生性糖尿病视网膜病变过程中内界膜剥离的解剖学和功能学变化。方法行睫状体平坦部玻璃体切割术的患者为轻到中度纤维组织增生,随机分成2组,第1组25例(26眼),仅行玻璃体切割术;第2组22例(23眼),行玻璃体切割联合黄(本文来源于《眼科新进展》期刊2008年12期）
阎静[4]（2008）在《睫状体平坦部玻璃体切割术后高眼压的药物治疗观察》一文中研究指出目的比较不同种抗青光眼滴眼剂在睫状体平坦部玻璃体切割术后对于高眼压的控制效果。方法将年龄在18～65岁,基线眼压为(16.62±3.40)mm Hg(1 mm Hg=0.133 kPa)的175例PPV术后发生高眼压的患者随机分为4组,分别使用3种抗青光眼药物滴眼。第1组56只眼,单一应用β阻滞剂。(本文来源于《中国眼底病论坛·全国眼底病专题学术研讨会论文汇编》期刊2008-03-01）
刘瑶,丁传凤,胡凯,汪竣岭,屠颖[5]（2008）在《经巩膜睫状体平坦部自闭切口玻璃体切割术疗效观察》一文中研究指出经巩膜睫状体平坦部的封闭式玻璃体切割术已经广泛应用于眼科临床,对治疗某些眼科疾病有不可替代的作用,目前虽然23G玻璃体切割技术已经成功应用于临床,但是其适应证依然有限,因此经典的20G玻璃体切割术仍然不可替代,而其术后巩膜缝线反应往往持续半年之久,给患者(本文来源于《江苏医药》期刊2008年01期）
Uhlmann,S.,Wiedemann,P.,喻平平[6]（2006）在《屈光性晶状体置换联合平坦部玻璃体切割术治疗高度近视》一文中研究指出Purpose: To describe the results of refractive lens exchange (RLE) combined with simultaneous pars plana vitrectomy (PPV) in the management of severe myopia. Methods: This retrospective study comprised 14 eyes of eight patients who had RLE to treat myopia of-19.0±5.4 diopters (D). Phacoemulsification, posterior chamber intraocular lens (IOL) implantation, and standard three-port vitrectomy were performed. Mean postoperative follow-up time was 30 months (range 12-49). Results: The postoperative best-corrected visual acuity (BCVA) was 0.68±0.23 compared to 0.37±0.24 preoperatively. There was no postoperative decrease in visual acuity in any eye. Mean postoperative spherical equivalent was-0.7 D (±1.6). At 30 months mean follow-up time, the spherical equivalents of nine eyes (64.3%) were within±1D of emmetropia. There was no significant change in astigmatism due to operative procedures. During the 30 months follow-up period three eyes (21.4%) required neodymium:yttrium-aluminium-garnet (Nd:YAG) capsulotomy for posterior capsule opacification. No retinal detachments or cases of cystoidmacular oedema (CME) were observed during the follow-up. Conclusion: RLE was effective in correcting severe myopia. The simultaneously performed PPV may reduce the risk of postoperative retinal detachment. This was a pilot study, to draw definitive conclusions a prospective study has to be initiated.(本文来源于《世界核心医学期刊文摘.眼科学分册》期刊2006年12期）
Patel,J.I.,Hykin,P.G.,Schadt,M.,喻平平[7]（2006）在《平坦部玻璃体切割术治疗糖尿病性黄斑水肿的光学相干断层成像和功能的相关性》一文中研究指出Purpose: A prospective study to evaluate the macular structural and functional effects of pars plana vitrectomy (PPV) for persistent diffuse clinically significant macular oedema (CSMO). Method: A total of 12 patients with persistent diffuse CSMO were recruited and underwent assessment including best-corrected visual acuity, fundus fluorescein angiography, optical coherence tomography (OCT) and fine matrix mapping (FMM)at baseline and over a period of a year poststandard three-port PPV. Results: The median baseline ETDRS letters score for all 12 patients was 52 (range 41-63) while at 12 months it had increased to 65 (range of 27-68), an improvement of two complete ETDRS lines (P=0.037). Similarly, there was an improvement in the perifoveal cone thresholds (P=0.02). The foveal thickening for all 12 patients ranged from a median of 183 to 751μm (normal range 126-180 μm) and the macular volume ranged from a median of 2.13 to 6.42mm3 (normal < 1.66 mm3). After surgery, both the median foveal thickness (from 334 to 280μm) and median macular volume (from 3.24 to 2.61mm3) demonstrated decreases over 12 months (P=0.01). On baseline OCT, the patients fell into two anatomically distinct groups: Group 1 (n=4) had a dome-shaped thickened macula with a partial posterior hyaloid separation and a significantly higher foveal thickness and macular volume than Group 2 (n=8)which had a diffuse low-elevation profile of the thickened macula (P=0.007). Conclusions: In this prospective study of PPV for persistent fovea-involving CSMO there was structural and functional improvement.(本文来源于《世界核心医学期刊文摘.眼科学分册》期刊2006年12期）
Patel,J.I.,Hykin,P.G.,SchadtM.,王海燕[8]（2006）在《糖尿病性黄斑水肿经平坦部玻璃体切割与黄斑部氩激光光凝的先导性随机试验》一文中研究指出Introduction: Focal macular photocoagulation for clinically significant macular oedema (CSME) is the proven method for treatment of this condition, but with little chance of visual improvement. Pars plana vitrectomy (PPV) may produce resolution of macular oedema and improvement in visual acuity. However, there have been no randomised trials to ascertain role of vitrectomy in the management of persistent CSME. Methods: Patients with persistent CSME despite previous macular photocoagulation and Snellen visual acuity 6/15 to 6/60 were recruited. Dilated fundoscopy, best-corrected visual acuity including Early Treatment Diabetic Retinopathy Study (ETDRS) vision, ocular coherence tomography and fundus fluorescein angiography (FFA) at baseline and up to 12 months post-treatment was performed. Exclusion criteria were signs of posterior vitreous detachment, macular traction or the taut posterior hyaloid face syndrome, or macular ischaemia on FFA. In all, 20 patients were randomised (10 in each arm) to either standard macular photocoagulation or PPV and removal of the posterior hyaloid face. Results: Of the 20 patients recruited, seven patients completed the protocol in the vitrectomy and eight in the laser arms, respectively. There was little evidence of any difference in the foveal thickness at 12 months between the two treatment arms despite a gradual improvement. Only one patient, from the vitrectomy arm, suffered moderate visual loss (defined as loss of 15 ETDRS letters) (our primary outcome). Discussion: In this pilot RCT, standard PPV provides little visual benefit compared tomacular photocoagulation,but a larger definitive study is required to confirmthis early appraisal.(本文来源于《世界核心医学期刊文摘.眼科学分册》期刊2006年12期）
Ohara,K.,Kato,S.,Hori,S.,Kitano,S.,杨秀梅[9]（2006）在《玻璃体切割术联合睫状体平坦部晶状体切开摘除术术后晶状体的倾斜和偏心》一文中研究指出Purpose:To investigate intraocular lens(IOL)tilt and decentration following combined vitrectomy and pars plana lensectomy(PPL)with IOL implantation in patients with proliferative diabetic retinopathy.Methods:We followed 25 patients with proliferative diabetic retinopathy who underwent PPL and IOL(MA60BM)implantation at the time of pars plana vitrectomy(PPL group),and 25 patients who underwent phacoemulsification and IOL(MA60BM)implantation without vitrectomy(PE group).Intraocular lens tilt and decentration were evaluated quantitatively,using the anterior eye segment analysis system,approximately 12 months after surgery.Results:There was no significant difference in IOL tilt(p=0.47)or decentration(p =0.26)between the PPL and PE groups.Conclusions:The present study suggests that tilt and decentration of the IOL are acceptable in combined vitrectomy and pars plana lensectomy.(本文来源于《世界核心医学期刊文摘.眼科学分册》期刊2006年09期）
Colucciello,M,宋虎平[10]（2005）在《两切口经睫状体平坦部玻璃体切割术:回顾性干预性病例系列研究》一文中研究指出Background: and objective: Current literature review fails to disclose any series describing the use of two-port vitrectomy in adult patients. This study was performed to determine the feasibility and efficacy of pars plana vitrectomy surgery using two (rather than three or four)-port access for treatment of diabetic patients with nonclearing vitreous haemorrhage due to retinal neovascularization. Design: Interventional prospective case series: to measure ability to allow for long-term resolution of chronic uncomplicated vitreous haemorrhage in diabetic patients, and to study the frequency and nature of complications associated with this technique. Methods: Two-port pars plana vitrectomy (with endolaser treatment and membrane delamination if necessary) was performed in a prospective series of 12 consecutive diabetic patients with nonclearing vitreous haemorrhage due to retinal neovascularization. Results: Successful removal of vitreous haemorrhage resulted in all patients. No visually significant intraoperative complications occurred. Best postoperative visual acuity correlated with lenticular and macular perfusion status. Conclusion: Two-port pars plana vitrectomy is an efficient (and potentially safer and faster) alternative to the standard three-port vitrectomy in selected patients.(本文来源于《世界核心医学期刊文摘.眼科学分册》期刊2005年12期）
平坦部玻璃体切割术论文开题报告
（1）论文研究背景及目的
此处内容要求：
首先简单简介论文所研究问题的基本概念和背景，再而简单明了地指出论文所要研究解决的具体问题，并提出你的论文准备的观点或解决方法。
写法范例：
目的观察经睫状体平坦部玻璃体切割术联合激光光凝治疗Eales病的临床疗效。方法回顾性分析36例42眼经睫状体平坦部玻璃体切割术联合眼内激光治疗Eales病患者的临床资料。结果术后视力明显提高28眼(67%),术后视力提高37眼(88%),无提高5眼(12%)。结论经睫状体平坦部玻璃体切割联合激光光凝是治疗Eales病的有效方法。
（2）本文研究方法
调查法：该方法是有目的、有系统的搜集有关研究对象的具体信息。
观察法：用自己的感官和辅助工具直接观察研究对象从而得到有关信息。
实验法：通过主支变革、控制研究对象来发现与确认事物间的因果关系。
文献研究法：通过调查文献来获得资料，从而全面的、正确的了解掌握研究方法。
实证研究法：依据现有的科学理论和实践的需要提出设计。
定性分析法：对研究对象进行“质”的方面的研究，这个方法需要计算的数据较少。
定量分析法：通过具体的数字，使人们对研究对象的认识进一步精确化。
跨学科研究法：运用多学科的理论、方法和成果从整体上对某一课题进行研究。
功能分析法：这是社会科学用来分析社会现象的一种方法，从某一功能出发研究多个方面的影响。
模拟法：通过创设一个与原型相似的模型来间接研究原型某种特性的一种形容方法。
平坦部玻璃体切割术论文参考文献
[1].刘志强,孙元英.经睫状体平坦部行晶状体后囊膜切开联合前段玻璃体切割治疗后发性白内障的疗效观察[J].中华临床医师杂志(电子版).2015
[2].何异,唐晓昭.经睫状体平坦部玻璃体切割术并腔内激光治疗Eales病[J].四川医学.2009
[3].付中静.睫状体平坦部玻璃体切割术联合或不联合内界膜剥离术治疗纤维组织增生性糖尿病[J].眼科新进展.2008
[4].阎静.睫状体平坦部玻璃体切割术后高眼压的药物治疗观察[C].中国眼底病论坛·全国眼底病专题学术研讨会论文汇编.2008
[5].刘瑶,丁传凤,胡凯,汪竣岭,屠颖.经巩膜睫状体平坦部自闭切口玻璃体切割术疗效观察[J].江苏医药.2008
[6].Uhlmann,S.,Wiedemann,P.,喻平平.屈光性晶状体置换联合平坦部玻璃体切割术治疗高度近视[J].世界核心医学期刊文摘.眼科学分册.2006
[7].Patel,J.I.,Hykin,P.G.,Schadt,M.,喻平平.平坦部玻璃体切割术治疗糖尿病性黄斑水肿的光学相干断层成像和功能的相关性[J].世界核心医学期刊文摘.眼科学分册.2006
[8].Patel,J.I.,Hykin,P.G.,SchadtM.,王海燕.糖尿病性黄斑水肿经平坦部玻璃体切割与黄斑部氩激光光凝的先导性随机试验[J].世界核心医学期刊文摘.眼科学分册.2006
[9].Ohara,K.,Kato,S.,Hori,S.,Kitano,S.,杨秀梅.玻璃体切割术联合睫状体平坦部晶状体切开摘除术术后晶状体的倾斜和偏心[J].世界核心医学期刊文摘.眼科学分册.2006
[10].Colucciello,M,宋虎平.两切口经睫状体平坦部玻璃体切割术:回顾性干预性病例系列研究[J].世界核心医学期刊文摘.眼科学分册.2005